HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.

Abstract
Pregnancy malaria is caused by Plasmodium falciparum-infected erythrocytes that adhere to the placental receptor chondroitin sulfate A (CSA) and sequester in the placenta; women become resistant to pregnancy malaria as they acquire antiadhesion antibodies that target surface proteins of placental parasites. VAR2CSA, a member of the P. falciparum EMP1 variant surface antigen family, is the leading candidate for a pregnancy malaria vaccine. Because VAR2CSA is a high-molecular-weight protein, a vaccine based on the full-length protein may not be feasible. An alternative approach has been to develop a vaccine targeting individual Duffy binding-like (DBL) domains. In this study, a consortium of laboratories under the Pregnancy Malaria Initiative compared the functional activity of antiadhesion antibodies elicited by different VAR2CSA domains and variants produced in prokaryotic and eukaryotic expression systems. Antisera were initially tested against laboratory lines of maternal parasites, and the most promising reagents were evaluated in the field against fresh placental parasite samples. Recombinant proteins expressed in Escherichia coli elicited antibody levels similar to those expressed in eukaryotic systems, as did the two allelic forms of the DBL4 and DBL5 domains. The procedures developed for this head-to-head comparison will be useful for future evaluation and down-selection of malaria vaccine immunogens.
AuthorsMichal Fried, Marion Avril, Richa Chaturvedi, Pablo Fernandez, Joseph Lograsso, David Narum, Morten A Nielsen, Andrew V Oleinikov, Mafalda Resende, Ali Salanti, Tracy Saveria, Kathryn Williamson, Alassane Dicko, Artur Scherf, Joseph D Smith, Thor G Theander, Patrick E Duffy
JournalInfection and immunity (Infect Immun) Vol. 81 Issue 2 Pg. 487-95 (Feb 2013) ISSN: 1098-5522 [Electronic] United States
PMID23208604 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Immune Sera
  • Immunoglobulin G
  • Malaria Vaccines
  • Recombinant Proteins
  • Chondroitin Sulfates
Topics
  • Animals
  • Antibodies, Protozoan (immunology)
  • Antigens, Protozoan (immunology)
  • Chondroitin Sulfates (immunology)
  • Cohort Studies
  • Female
  • Humans
  • Immune Sera (immunology)
  • Immunoglobulin G (immunology)
  • Longitudinal Studies
  • Malaria Vaccines (immunology, pharmacology)
  • Malaria, Falciparum (immunology, prevention & control)
  • Placenta (immunology)
  • Plasmodium falciparum (immunology)
  • Pregnancy
  • Pregnancy Complications, Parasitic (immunology, prevention & control)
  • Rats
  • Recombinant Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: